Results

Total Results: 1,920 records

Showing results for "estimate".

1741. Disposition of Comments Report for Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients Wtih Kidney Disease (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_disposition-comments.pdf
      August 11, 2014 - Disposition of Comments Report for Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients Wtih Kidney Disease Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease …

1742. Interventions Targeting Sensory Challenges in Children With Autism Spectrum Disorders - An Update (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-interventions-disposition.pdf
      May 26, 2017 - Interventions Targeting Sensory Challenges in Children With Autism Spectrum Disorders - An Update Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Interventions Targeting Sensory Challenges in Children With Autism Spectrum Disorder (ASD)—An Update Draft review ava…

1743. Comparative Effectiveness of Coronary Bypass Surgery and Percutaneous Coronary Interventions for Multivessel Disease: A Pooled Analysis of Individual Patient Data from Ten Randomized Trials (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
      February 01, 2010 - Comparative Effectiveness of Coronary Bypass Surgery and Percutaneous Coronary Interventions for Multivessel Disease: A Pooled Analysis of Individual Patient Data from Ten Randomized Trials Comparative Effectiveness Review Number 9 Addendum Addendum to: Comparative Effectiveness of Percutane…

1744. Draft-Appendix-Pbt-Study-Details-Results-Evidence-Tables (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/draft-appendix-pbt-study-details-results-evidence-tables.xlsx
      May 11, 2021 - E-1. Can. Study Characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, months Psychiatric Co…

1745. Plant-Based-Chronic-Pain-Review-Q3-Tables-F1-4 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-chronic-pain-review-q3-tables-f1-4.xlsx
      June 15, 2021 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % Pain Duration Measure (Me…

1746. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2.xlsx
      January 22, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

1747. Pbt-Lsr-Draft-Ets-Rcts (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-draft-ets-rcts.xlsx
      March 15, 2022 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

1748. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0.xlsx
      February 16, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

1749. Appendix-E-Evidence-Tables-E1-E4 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4.xlsx
      November 04, 2021 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

1750. Cannabis-2022-Update-Surv-Rep-1-App-F1-4 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
      January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

1751. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
      January 01, 2022 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

1752. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 0 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
      February 16, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

1753. Comparative Effectiveness Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
      January 01, 2006 - Comparative Effectiveness Review 118 Appendix A. Pharmacokinetics, Indications and Dosing of Included Drugs Drug and Trade Name (Trade names provided only for drugs under patent.) Half-life or other relevant pharmacokinetic feature Labeled indications Dosing (oral doses) Dose adjustments fo…

1754. Appendix-E-Evidence-Tables-E1-E4 0 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
      November 04, 2021 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

1755. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
      April 01, 2022 - The estimate for 50 MME or more did not indicate increased risk but was very imprecise (adjusted OR

1756. Pharma-Nonpharma-Ptsd-2023-Update-App-G-2 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2023-update-app-g-2.xlsx
      January 01, 2023 - 2.6 Was an appropriate analysis used to estimate the effect of assignment to intervention?

1757. Disposition of Comments_Comparative Effectiveness Review No. 249: Malnutrition in Hospitalized Adults: A Systematic Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-249-malnutrition-disposition-comments_0.pdf
      October 13, 2021 - Disposition of Comments_Comparative Effectiveness Review No. 249: Malnutrition in Hospitalized Adults: A Systematic Review Comparative Effectiveness Review Disposition of Comments Report Title: Malnutrition in Hospitalized Adults: A Systematic Review Draft report available for public comment from Jun…

1758. Disposition of Comments_Comparative Effectiveness Review No. 249: Malnutrition in Hospitalized Adults: A Systematic Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-249-malnutrition-disposition-comments_0_0.pdf
      October 13, 2021 - Disposition of Comments_Comparative Effectiveness Review No. 249: Malnutrition in Hospitalized Adults: A Systematic Review Comparative Effectiveness Review Disposition of Comments Report Title: Malnutrition in Hospitalized Adults: A Systematic Review Draft report available for public comment from Jun…

1759. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
      September 01, 2012 - Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs Future Research Needs Paper Number 23 Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs Future Research Nee…

1760. Disposition of Comments for Pressure Ulcer Treatment Strategies: Comparative Effectiveness (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_disposition-comments.pdf
      May 08, 2013 - evidence reflects the true effect and that further research is likely to change the confidence in the estimate